Expert Analysis

Endocrine Therapy

Source: CCO Independent Conference Coverage of the 2006 Annual San Antonio Breast Cancer Symposium*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Endocrine Therapy


Faculty:

  • Nancy E. Davidson, MD
  • Peter Ravdin, MD, PhD
  • Christy Russell, MD

CME CREDIT INFORMATION

Release Date: 02/08/07

Expiration Date: 02/07/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status



Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the results of recent clinical trial studies for the treatment of early-stage breast cancer
  • Describe optimal treatment regimens for treating early-stage breast cancer patients
  • Recall methods to measure and/or predict responses associated with breast cancer regimens

Topics covered include:

  • The Use of Adjuvant Luteinizing Hormone-Releasing Hormone Agonists
  • The EFECT Trial
  • Prognostic Value of Treatment-Induced Amenorrhea
  • Predicting Tamoxifen’s Benefit With the 21-Gene Recurrence Score Assay
  • 81-Gene Signature and Optimization of Endocrine Treatment
  • Estrogen-Related Gene Expression and Response to AIs
  • ER Expression, PR Expression, HER-2 Status, and Disease Recurrence
  • NSABP B-33
  • Age-Related Outcomes in the MA.17 Trial
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.

CCO Resources

Treatment of Endocrine Responsive Breast Cancer